Literature DB >> 2785956

The p24 leucocyte membrane antigen: modulation associated with lymphocyte activation and differentiation.

H Zola1, V Furness, S Barclay, H Zowtyj, M Smith, J V Melo, S H Neoh, J Bradley.   

Abstract

Monoclonal antibodies of the CD9 cluster recognize a 24 kD protein (p24) found on platelets and endothelium, and expressed by lymphocytes at restricted stages of maturation and activation. In this study, we explore the possibility that p24 is involved in the response of lymphocytes to signals delivered by lymphokines. p24 is expressed only very weakly by resting B lymphocytes. We found no increase in expression when cells were activated with anti-immunoglobulin together with interleukin-4, or induced to proliferate by low-molecular weight B cell growth factor (LMW-BCGF). Culture of activated B cells with B cell differentiation factor was associated with an increased mean expression of p24. In cells from a patient with chronic lymphocytic leukaemia (CLL), culture with LMW-BCGF up-regulated p24 expression. Resting T cells (p24-negative) were induced to express p24 strongly when activated with antibody against CD3. CD9 antibody did not modulate B or T cell responses to activation stimuli. The results suggest that the p24 molecule is not involved in the primary interaction of cells with lymphokine, but rather may be involved in a secondary reaction, such as ion flux, which follows as a consequence of the action of lymphokines on cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2785956     DOI: 10.1038/icb.1989.8

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  3 in total

1.  Anti-CD9 antibodies augment neutrophil adherence to endothelium.

Authors:  K D Forsyth
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

2.  Lymphocyte surface marker expression in rheumatic diseases: evidence for prior activation of lymphocytes in vivo.

Authors:  M D Smith; P J Roberts-Thomson
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

3.  Enkephalins stimulate leukemia cell migration and surface expression of CD9.

Authors:  W Heagy; K Duca; R W Finberg
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.